Bioprosthetic Valve Thrombosis while on a Novel Oral Anticoagulant for Atrial Fibrillation

[Display omitted] •BPVT occurred while on a DOAC for treatment of AF.•Echocardiographic and pathologic images of BPVT are shown.•The definition of NVAF is not uniform in clinical trials or guidelines.•The optimal anticoagulation strategy for BPV and AF is unclear.•Caution is advised in using DOACs f...

Full description

Saved in:
Bibliographic Details
Published in:CASE (Philadelphia, Pa.) Pa.), 2018-04, Vol.2 (2), p.54-58
Main Authors: O'Callaghan, Marissa, Chester, Rebecca, Scheckel, Caleb, Lee, Justin Z., Fernandes, Regis, Shamoun, Fadi
Format: Article
Language:English
Subjects:
Anticoagulation
Atrial fibrillation
Bioprosthetic valve
Masses, Clots, Thrombus, Butterfly…or a Bullet?
Thrombosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Display omitted] •BPVT occurred while on a DOAC for treatment of AF.•Echocardiographic and pathologic images of BPVT are shown.•The definition of NVAF is not uniform in clinical trials or guidelines.•The optimal anticoagulation strategy for BPV and AF is unclear.•Caution is advised in using DOACs for AF in patients with BPVs.
ISSN:2468-6441
2468-6441
DOI:10.1016/j.case.2017.11.002